While some components did not show clear trends for up- or downregulation in response to the mutational status of FLT3 in the various data sets, the expression of several genes was significantly altered in FLT3 ITD-positive AML samples in individual data sets. This evidence concerns the gene FLT3 and acute myeloid leukemia.